INmune Bio, Inc. (INMB)
1.25
+0.01
(+0.81%)
USD |
NASDAQ |
Jun 09, 11:30
INmune Bio EPS Diluted (TTM) : -1.695 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Sangamo Therapeutics, Inc. | -0.383 |
| Arrowhead Pharmaceuticals, Inc. | -2.148 |
| Oncolytics Biotech, Inc. | -0.2517 |
| Sarepta Therapeutics, Inc. | -0.9641 |
| Anixa Biosciences, Inc. | -0.3149 |